| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10743604 | Maturitas | 2013 | 4 Pages |
Abstract
Symptoms related to vaginal atrophy are a significant problem for postmenopausal women and estrogen has been the gold standard for its treatment. A number of recent reviews of vaginal estrogen products are available. This review will, therefore, focus on other products and potential products for this indication, including the tissue selective estrogen complex and selective estrogen receptor modulators. Additionally, lesser-studied approaches will be discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
James H. Pickar,